Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon.

Helmink BA, Roland CL, Kiernan CM, Wargo JA.

Ann Surg Oncol. 2020 Jan 21. doi: 10.1245/s10434-019-08183-0. [Epub ahead of print]

PMID:
31965370
2.

B cells are associated with survival and immunotherapy response in sarcoma.

Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH.

Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.

PMID:
31942077
3.

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.

Keung EZ, Burgess M, Salazar R, Parra Cuentas E, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno S, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke DK, Lazar AJ, Wang WL, Wargo JA, Tawbi HA.

Clin Cancer Res. 2020 Jan 3. pii: clincanres.1824.2019. doi: 10.1158/1078-0432.CCR-19-1824. [Epub ahead of print]

PMID:
31900276
4.

Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin.

Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BW.

J Surg Oncol. 2019 Dec 17. doi: 10.1002/jso.25807. [Epub ahead of print]

PMID:
31846095
5.

Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection.

Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD.

Am J Surg. 2019 Nov 30. pii: S0002-9610(19)31540-5. doi: 10.1016/j.amjsurg.2019.11.026. [Epub ahead of print]

PMID:
31843190
6.

Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.

Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA.

Am J Clin Oncol. 2019 Oct;42(10):744-748. doi: 10.1097/COC.0000000000000590.

PMID:
31436747
7.

Modeling the potential impact of abuse-deterrent opioids on medical resource utilization.

Yenikomshian MA, White AG, Carson ME, Jia ZB, Mendoza MR, Roland CL.

J Med Econ. 2019 Oct;22(10):1073-1079. doi: 10.1080/13696998.2019.1645680. Epub 2019 Aug 13.

PMID:
31314616
8.

The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum.

Chrisinger JSA, Al-Zaid T, Keung EZ, Leung C, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wang WL.

J Surg Oncol. 2019 Sep;120(3):382-388. doi: 10.1002/jso.25585. Epub 2019 Jun 17.

PMID:
31206726
9.

MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.

Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J.

Cancers (Basel). 2019 May 15;11(5). pii: E677. doi: 10.3390/cancers11050677.

10.

Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients.

Cicero TJ, Mendoza M, Cattaneo M, Dart RC, Mardekian J, Polson M, Roland CL, Schnoll SH, Webster LR, Park PW.

Postgrad Med. 2019 Apr;131(3):225-229. doi: 10.1080/00325481.2019.1585688. Epub 2019 Mar 19.

PMID:
30794760
11.

Radiation and Its Impact on Local Recurrence in Extremity and Trunk Well-Differentiated Liposarcomas.

Fonseca AL, Roland CL, Cormier JN, Torres KE, Hunt KH, Bishop AJ, Guadagnolo A, Feig BW.

Am Surg. 2019 Jan 1;85(1):52-58.

PMID:
30760345
12.

Window-of-Opportunity Trials: The Road Forward in Soft Tissue Sarcoma and Beyond.

Keung EZ, Roland CL.

Ann Surg Oncol. 2019 May;26(5):1188-1189. doi: 10.1245/s10434-019-07193-2. Epub 2019 Jan 24. No abstract available.

PMID:
30680475
13.

Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery.

Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA.

Am J Clin Oncol. 2019 Mar;42(3):238-242. doi: 10.1097/COC.0000000000000515.

PMID:
30614820
14.

The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.

Roland CL, Ye X, Stevens V, Oderda GM.

J Manag Care Spec Pharm. 2019 Jan;25(1):18-27. doi: 10.18553/jmcp.2019.25.1.018.

15.

Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients.

Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1167-1174. doi: 10.1016/j.ijrobp.2018.12.012. Epub 2018 Dec 12.

PMID:
30552963
16.

Accurate and Reproducible Diagnosis of Canine Soft Tissue Sarcoma Using Mass Spectrometry: A Step in the Right Direction.

Keung EZ, Roland CL.

Cancer Cell. 2018 Nov 12;34(5):697-699. doi: 10.1016/j.ccell.2018.10.013.

17.

An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?

Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL.

Am J Clin Oncol. 2019 Feb;42(2):160-165. doi: 10.1097/COC.0000000000000486.

PMID:
30394881
18.

ASO Author Reflections: Location-Specific Staging in Sarcoma-A Step in the Right Direction.

Fisher SB, Roland CL.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):930-931. doi: 10.1245/s10434-018-6900-0. Epub 2018 Oct 15. No abstract available.

PMID:
30324474
19.

Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.

20.

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.

Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL.

BMC Cancer. 2018 Sep 24;18(1):913. doi: 10.1186/s12885-018-4829-0.

21.

Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD.

Gastric Cancer. 2018 Nov;21(6):1004-1013. doi: 10.1007/s10120-018-0832-z. Epub 2018 May 5.

22.

Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum.

Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW.

Am Surg. 2018 Apr 1;84(4):570-575.

PMID:
29712608
23.

Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.

Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002386. doi: 10.1101/mcs.a002386. Print 2018 Apr.

24.

Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit.

Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW.

Ann Surg Oncol. 2018 Aug;25(8):2193-2200. doi: 10.1245/s10434-018-6417-6. Epub 2018 Mar 8.

25.

Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities.

Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL.

Ann Surg Oncol. 2018 May;25(5):1126-1132. doi: 10.1245/s10434-018-6378-9. Epub 2018 Feb 21.

26.

Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.

Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW.

J Surg Oncol. 2018 Apr;117(5):879-885. doi: 10.1002/jso.24988. Epub 2018 Feb 15.

27.

Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.

Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD.

Cancer. 2018 Mar 1;124(5):998-1007. doi: 10.1002/cncr.31155. Epub 2018 Feb 2.

28.

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology.

Setnik B, Schoedel KA, Levy-Cooperman N, Shram M, Pixton GC, Roland CL.

J Opioid Manag. 2017 Nov/Dec;13(6):485-523. doi: 10.5055/jom.2017.0412. Review.

PMID:
29308594
29.

Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL.

Oncoimmunology. 2017 Oct 31;7(2):e1385689. doi: 10.1080/2162402X.2017.1385689. eCollection 2018.

30.

Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US.

Banerjee S, Roland CL, Willke R, Mardekian J, Garrison LP Jr.

J Pain Palliat Care Pharmacother. 2017 Sep - Dec;31(3-4):218-227. doi: 10.1080/15360288.2017.1407860. Epub 2017 Dec 20.

PMID:
29261401
31.

Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.

Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW.

J Surg Oncol. 2018 May;117(6):1188-1194. doi: 10.1002/jso.24951. Epub 2017 Dec 11.

PMID:
29228466
32.

Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma.

Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Eur J Surg Oncol. 2018 Jan;44(1):170-177. doi: 10.1016/j.ejso.2017.11.014. Epub 2017 Nov 27.

33.

Educational intervention for physicians to address the risk of opioid abuse.

Pasquale MK, Sheer RL, Mardekian J, Masters ET, Patel NC, Hurwitch AR, Weber JJ, Jorga A, Roland CL.

J Opioid Manag. 2017 Sep/Oct;13(5):303-313. doi: 10.5055/jom.2017.0399.

PMID:
29199396
34.

Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.

Yenikomshian MA, White AG, Carson ME, Garrison LP, Oderda GM, Biskupiak JE, Hlavacek PR, Roland CL.

J Opioid Manag. 2017 Sep/Oct;13(5):291-301. doi: 10.5055/jom.2017.0398.

PMID:
29199395
35.

Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases.

Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad C.

Ann Surg Oncol. 2018 Jan;25(1):107-116. doi: 10.1245/s10434-017-6144-4. Epub 2017 Nov 7.

PMID:
29116489
36.

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.

Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N.

Sci Rep. 2017 Sep 19;7(1):11836. doi: 10.1038/s41598-017-12132-w.

37.

The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste-Reply.

Ikoma N, Araujo D, Roland CL.

JAMA Oncol. 2017 Dec 1;3(12):1740. doi: 10.1001/jamaoncol.2017.2503. No abstract available.

38.

Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.

Voss RK, Chiang YJ, Torres KE, Guadagnolo BA, Mann GN, Feig BW, Cormier JN, Roland CL.

Ann Surg Oncol. 2017 Oct;24(11):3271-3278. doi: 10.1245/s10434-017-6015-z. Epub 2017 Jul 24.

39.

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP.

Clin Sarcoma Res. 2017 Jun 15;7:11. doi: 10.1186/s13569-017-0077-3. eCollection 2017.

40.

Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery.

Ikoma N, Torres KE, Lin HY, Ravi V, Roland CL, Mann GN, Hunt KK, Cormier JN, Feig BW.

J Surg Oncol. 2017 Sep;116(3):313-319. doi: 10.1002/jso.24667. Epub 2017 May 29.

41.

Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.

Smith SM, Jones JK, Katz NP, Roland CL, Setnik B, Trudeau JJ, Wright S, Burke LB, Comer SD, Dart RC, Dionne R, Haddox JD, Jaffe JH, Kopecky EA, Martell BA, Montoya ID, Stanton M, Wasan AD, Turk DC, Dworkin RH.

J Pain. 2017 Nov;18(11):1287-1294. doi: 10.1016/j.jpain.2017.03.015. Epub 2017 May 4.

42.

Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration.

Green JL, Bucher Bartelson B, Le Lait MC, Roland CL, Masters ET, Mardekian J, Bailey JE, Dart RC.

Drug Alcohol Depend. 2017 Jun 1;175:140-145. doi: 10.1016/j.drugalcdep.2017.01.039. Epub 2017 Mar 28.

43.

The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain.

Setnik B, Roland CL, Barsdorf AI, Brooks A, Coyne KS.

Curr Med Res Opin. 2017 Jun;33(6):1067-1076. doi: 10.1080/03007995.2017.1300142. Epub 2017 Apr 3.

PMID:
28277862
44.

Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.

Roland CL, Setnik B, Brown DA.

Postgrad Med. 2017 Jan;129(1):12-21. doi: 10.1080/00325481.2017.1272397. Epub 2016 Dec 25.

PMID:
27960575
45.

Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection.

Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB.

Surgery. 2017 Mar;161(3):753-759. doi: 10.1016/j.surg.2016.09.002. Epub 2016 Nov 3.

46.

Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review.

Roland CL, Lake J, Oderda GM.

J Pain Palliat Care Pharmacother. 2016 Dec;30(4):258-268. Epub 2016 Nov 1. Review.

PMID:
27802072
47.

Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.

Setnik B, Roland CL, Pixton GC, Sommerville KW.

Postgrad Med. 2017 Jan;129(1):5-11. doi: 10.1080/00325481.2017.1245585. Epub 2016 Oct 26.

PMID:
27782769
48.

Myxofibrosarcoma.

Roland CL, Wang WL, Lazar AJ, Torres KE.

Surg Oncol Clin N Am. 2016 Oct;25(4):775-88. doi: 10.1016/j.soc.2016.05.008. Epub 2016 Jul 30. Review.

PMID:
27591498
49.

Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales.

Setnik B, Roland CL, Pixton G, Webster L.

J Clin Pharmacol. 2017 Feb;57(2):266-274. doi: 10.1002/jcph.801. Epub 2016 Aug 23.

PMID:
27444046
50.

Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults.

Novak SP, Glasheen C, Roland CL.

Subst Abuse Rehabil. 2016 Jun 30;7:87-98. doi: 10.2147/SAR.S102251. eCollection 2016.

Supplemental Content

Loading ...
Support Center